Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
Parapharyngeal Space Tumors
Ihab Samy, M.D.
Lecturer of Surgical Oncology
National Cancer Institute,Cairo-Eypt
2013
• Account for 0.5 - 1% of all head and neck
neoplasms
• Benign: 80% and Malignant: 20%
• Surgical excision is the primary ...
Anatomy
• Inverted pyramid with
floor at skull base, tip
at hyoid
• Potential space
Superior Boundary
• Small portion of
temporal and
sphenoid bones
• Inferior: junction of the posterior belly of the
digastric muscle and greater cornu of the
hyoid bone.
• Medially: bucco...
• Anterior: the pterygomandibular raphe.
• Posterior: the dorsal layer of fascia of the
carotid sheath.
Internal carotid a...
Prestyoid vs Retrostyloid
• Key anatomical division of PPS
• Tensor-vascular styloid fascia divides into
prestyloid and re...
Prestyloid space
• Located in the
anteromrdial aspect of
the parapharyngeal
space
• Contains the
retromandibular
portion o...
Prestyloid compartment
• Fat (Adipose tissue).
• Retromandibular parotid.
• Lymph nodes.
Retrostyloid compartment
• Internal carotid artery.
• Jugular vein.
• Sympathetic chain.
• Cranial nerves IX-XII.
• Lymph ...
Prestyloid space
• 40-50% are salivary gland neoplasms.
• 80-90% are benign- pleomorphic adenoma.
• 20% are malignant- muc...
Poststyloid Space
• 20-30% are neurogenic in origin.
• Schwannoma accounts for the most common
benign tumor, followed by p...
Stylomandibular Tunnel
• Posterior ramus of the mandible
• Stylomandibular ligament
• Skull base
• Path for deep parotid t...
Primary Tumors
Three categories:
•Salivary gland tumors.
•Neurogenic tumors.
•Miscellaneous tumors.
Salivary Gland Tumors
• Most common PPS neoplasms: 40-50%.
• Prestyloid masses.
• Pleomorphic adenoma 80-90%.
• Mucoepider...
Salivary Gland Tumors
• Located in prestyloid space.
• From deep lobe of parotid or minor salivary
glands.
• On CT or MRI ...
Neurogenic Tumors: 17-25%
• Schwannoma or neurilemminoma.
• Paraganglioma.
• Neurofibroma.
Schwannoma
• Most common neurogenic neoplasm.
• Vagus, sympathetic chain most common site
of origin.
• Benign and slow gro...
Paraganglioma
• Second most common.
• Arise from vagus, from carotid body, or from jugular
bulb.
• Bilateral 10%, familial...
• Secrete catecholamines 1-3%.
• Malignant 3-10%.
• Glomus vagale displace carotid anteriorly
• Carotid body tumors splay ...
Neurofibromas
• 3rd
most common neurogenic tumor.
• From Schwann cells and fibroblasts
• Non-capsulated (involve nerve).
•...
NF1
•Affects one in 3,500 births.
•Affects the peripheral nervous system.
•Is caused by a mutation in the NF1 gene on
chro...
Miscellaneous Tumors
• Wide variety of tumors
• 20% of total PPS tumors
• Lymphoma, hemangioma, teratoma,
lipoma, branchia...
Clinical evaluation
• Deep neck space so
must reach 2-3 cm
before palpable.
• Neck mass 53%.
• Oropharygeal bulge
51%.
• Dysphagia, dyspnea,
• Unilateral effusion
• pulsatile tinnitus,
bruit, thrill, otalgia
• airway obstruction,
• hoarsenes...
• Complete head and neck exam
• Bimanual palpation
• Classically, paragangliomas mobile anterior-
posterior but not up and...
• If paraganglioma is suspected need to check
24 hour urine for catecholamines: VMA,
metanephrines, etc
• Metaiodinated be...
Imaging
• CT
• MRI/MRA
• angiography
CT
• Locates tumor to prestyloid vs retrostyloid.
• Fat plane between mass and parotid
• Displacement of carotid Artery.
•...
MRI
• Most useful study.
• Relationship of mass and carotid more easily
seen than with CT.
• Characteristic appearances of...
Pleomorphic adenoma
• Low signal intensity on T1
• High signal intensity on T2
• Displace carotid posteriorly
NB:NB: T1 im...
Schwannoma
• High signal intensity on T2
• Displace carotid anteriorly
Paraganglioma
•“Salt and pepper” appearance
•Displace carotid anteriorly
Angiography
• Used to all enhancing lesions.
• Gold standard for relationship to great
vessels.
• Differentiate neurogenic...
“Lyre” sign
Treatment
• Mainly surgical excision.
• Radiation therapy and chemotherapy mainly
for:
1-Poor surgical candidates.
2-Unres...
• Tumor embolization can be performed on
paragangliomas 24 hours prior to procedure.
• May cause fibrosis making dissectio...
Surgical Approaches
• Depends on the location, size, vascular status,
and suspicion for malignancy.
• Goal is to achieve o...
Surgical approaches
• Trans-oral.
• Trans-cervical +/- Mandibulotomy.
• Trans-parotid.
• Cervical-transpharyngeal “swing”....
Transoral
• Has been used for small, benign tumors.
• Very limited exposure and view.
• Increased risk of tumor spillage.
...
Trans-cervical
• With or without
mandibulotomy
• Transverse incision at level of
hyoid, two fingers breadth
below the mand...
Transparotid
• For deep lobe parotid tumors.
• Superficial parotidectomy.
• Facial nerve retracted.
• Dissect around mandi...
Cervical-parotid
• Extend cervical incision up infront of ear.
• Allows identification facial nerve.
• Divide posterior be...
Cervical-transpharyngeal
• “mandibular swing”
• Large (greater than
8cm)
• Highly vascular tumors.
• Mandibulotomy
anterio...
Infratemporal fossa
• Preauricular lateral infratemporal fossa
approach.
• Skull base +/- intra-cranial extension or
infra...
Transcervical-transmastoid
• Cervical incision
carried postauricularly
• cortical
mastoidectomy.
• Remove mastoid tip
expo...
Nonsurgical Management
• Poor surgical canidates, failed balloon
occlusion, elderly, unresectable lesions, would
require s...
Observation
• Paraganliomas grow 1.0-1.5 mm per year
• Benign
• Mortality less than 10% per year for untreated
Radiation
• Not curable
• Used for local control
• Some shrink, mostly stops growth
• Local control 90-100% reported
Key things to remember:
• Prestyloid vs. retrostyloid
• Pleomorphic most common prestyloid
• Neurogenic tumors are retrost...
Thank you
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Parapharyngeal space tumours
Nächste SlideShare
Wird geladen in …5
×

Parapharyngeal space tumours

  • Als Erste(r) kommentieren

Parapharyngeal space tumours

  1. 1. Parapharyngeal Space Tumors Ihab Samy, M.D. Lecturer of Surgical Oncology National Cancer Institute,Cairo-Eypt 2013
  2. 2. • Account for 0.5 - 1% of all head and neck neoplasms • Benign: 80% and Malignant: 20% • Surgical excision is the primary treatment.
  3. 3. Anatomy • Inverted pyramid with floor at skull base, tip at hyoid • Potential space
  4. 4. Superior Boundary • Small portion of temporal and sphenoid bones
  5. 5. • Inferior: junction of the posterior belly of the digastric muscle and greater cornu of the hyoid bone. • Medially: buccopharyngeal fascia over the superior constrictor muscle. • Laterally: fascia overlying the medial pterygoid muscle, the ramus of the mandible, and the fascia overlying the retromandibular parotid.
  6. 6. • Anterior: the pterygomandibular raphe. • Posterior: the dorsal layer of fascia of the carotid sheath. Internal carotid artery, jugular vein, CN IX-XII, sympathetic chain all course through this space.
  7. 7. Prestyoid vs Retrostyloid • Key anatomical division of PPS • Tensor-vascular styloid fascia divides into prestyloid and retrostyloid spaces • Antero-lateral prestyloid/posteror-medial retrostyloid • Used to make differential diagnosis based on imaging.
  8. 8. Prestyloid space • Located in the anteromrdial aspect of the parapharyngeal space • Contains the retromandibular portion of the deep lobe of the parotid gland, adipose tissue, small nerves, and ectopic salivary tissue, and lymph nodes. Poststyloid space • Located in the posterolateral aspect of the parapharyngeal space • Contains the carotid artery, jugular vein, cranial nerves IX,X,XI,XII, the sympathetic chain, paraganglia,and lymph nodes.
  9. 9. Prestyloid compartment • Fat (Adipose tissue). • Retromandibular parotid. • Lymph nodes.
  10. 10. Retrostyloid compartment • Internal carotid artery. • Jugular vein. • Sympathetic chain. • Cranial nerves IX-XII. • Lymph nodes.
  11. 11. Prestyloid space • 40-50% are salivary gland neoplasms. • 80-90% are benign- pleomorphic adenoma. • 20% are malignant- mucoepidermoid ca.,acinic cell carcinoma or carcinoma ex pleomorphic adenoma. • Major vessels are displaced posteriorly and parapharyngeal fat pad displaced medially
  12. 12. Poststyloid Space • 20-30% are neurogenic in origin. • Schwannoma accounts for the most common benign tumor, followed by paragangliomas and neurofibromas. • Major vessels are displaced anteriorly
  13. 13. Stylomandibular Tunnel • Posterior ramus of the mandible • Stylomandibular ligament • Skull base • Path for deep parotid tumors
  14. 14. Primary Tumors Three categories: •Salivary gland tumors. •Neurogenic tumors. •Miscellaneous tumors.
  15. 15. Salivary Gland Tumors • Most common PPS neoplasms: 40-50%. • Prestyloid masses. • Pleomorphic adenoma 80-90%. • Mucoepidermoid ca. most common malignancy. • Less than 5% parotid tumors involve the PPS.
  16. 16. Salivary Gland Tumors • Located in prestyloid space. • From deep lobe of parotid or minor salivary glands. • On CT or MRI a fat plane between the parotid and a prestyloid mass indicates minor salivary gland origin. • Displace the internal carotid posteriorly.
  17. 17. Neurogenic Tumors: 17-25% • Schwannoma or neurilemminoma. • Paraganglioma. • Neurofibroma.
  18. 18. Schwannoma • Most common neurogenic neoplasm. • Vagus, sympathetic chain most common site of origin. • Benign and slow growing. • Generally doesn’t affect nerve of origin. • Less than 1% malignant. • Displace internal carotid anteriorly.
  19. 19. Paraganglioma • Second most common. • Arise from vagus, from carotid body, or from jugular bulb. • Bilateral 10%, familial 30%. • Part of MEN IIA or IIB (medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia- with or without mucosal neuromas).
  20. 20. • Secrete catecholamines 1-3%. • Malignant 3-10%. • Glomus vagale displace carotid anteriorly • Carotid body tumors splay internal and external carotid – “lyre” sign
  21. 21. Neurofibromas • 3rd most common neurogenic tumor. • From Schwann cells and fibroblasts • Non-capsulated (involve nerve). • Multiple. • Part of Neurofibromatosis type I.
  22. 22. NF1 •Affects one in 3,500 births. •Affects the peripheral nervous system. •Is caused by a mutation in the NF1 gene on chromosome 17. •Is characterized by: 1.6 or more cafe-au-lait spots (light brown spots similar to birthmarks) on the skin. 2.Pea shaped bumps on or under the skin (neurofibromas). 3.Large areas on the skin that look enlarged (plexiform neurofibromas). 4.Freckling in the groin area and under the arms. 5.Spots on the iris of the eye (Lisch nodules). 6.Skeletal abnormalities such as scoliosis, bowing of the legs, or thinning of the shin bones. 7.50% of people with NF1 have learning disabilities. NF2 • Affects one in 40,000 births • Affects the central nervous system • Is caused by a mutation in the NF2 gene on chromosome 22 • Is characterized by: 1. multiple brain and spinal tumors 2. tumors on both auditory nerves 3. Manifestations commonly include: • - deafness • - balance problems • - facial nerve paralysis • - spinal cord compression • - loss of mobility • - optic nerve tumors • - eye function problems • - cataracts • - vision loss
  23. 23. Miscellaneous Tumors • Wide variety of tumors • 20% of total PPS tumors • Lymphoma, hemangioma, teratoma, lipoma, branchial cleft cyst, arteriovenous malformation, internal carotid artery aneurysm
  24. 24. Clinical evaluation • Deep neck space so must reach 2-3 cm before palpable. • Neck mass 53%. • Oropharygeal bulge 51%.
  25. 25. • Dysphagia, dyspnea, • Unilateral effusion • pulsatile tinnitus, bruit, thrill, otalgia • airway obstruction, • hoarseness • Horner’s syndrome, • dysarthria, • hypertension, flushing
  26. 26. • Complete head and neck exam • Bimanual palpation • Classically, paragangliomas mobile anterior- posterior but not up and down • FNA after imaging.
  27. 27. • If paraganglioma is suspected need to check 24 hour urine for catecholamines: VMA, metanephrines, etc • Metaiodinated benzylguanidine (MIBG)
  28. 28. Imaging • CT • MRI/MRA • angiography
  29. 29. CT • Locates tumor to prestyloid vs retrostyloid. • Fat plane between mass and parotid • Displacement of carotid Artery. • Enhancement of the lesion. • Bone erosion due to malignancy. • Limited soft tissue detail  MRI.
  30. 30. MRI • Most useful study. • Relationship of mass and carotid more easily seen than with CT. • Characteristic appearances of tumor types on MRI allows preoperative Dx in 90-95% of patients.
  31. 31. Pleomorphic adenoma • Low signal intensity on T1 • High signal intensity on T2 • Displace carotid posteriorly NB:NB: T1 images cause fat to appear bright, fat like the myelin in white matter. T2 weighted images cause water to appear bright like CSF and fat is dark.
  32. 32. Schwannoma • High signal intensity on T2 • Displace carotid anteriorly
  33. 33. Paraganglioma •“Salt and pepper” appearance •Displace carotid anteriorly
  34. 34. Angiography • Used to all enhancing lesions. • Gold standard for relationship to great vessels. • Differentiate neurogenic and vascular. • Remember “lyre” sign. • Balloon occlusion test if possible sacrifice of ICA.
  35. 35. “Lyre” sign
  36. 36. Treatment • Mainly surgical excision. • Radiation therapy and chemotherapy mainly for: 1-Poor surgical candidates. 2-Unresectability. 3-Failure of balloon occlusion test.
  37. 37. • Tumor embolization can be performed on paragangliomas 24 hours prior to procedure. • May cause fibrosis making dissection difficult.
  38. 38. Surgical Approaches • Depends on the location, size, vascular status, and suspicion for malignancy. • Goal is to achieve optimal exposure and vascular control without significant morbidity.
  39. 39. Surgical approaches • Trans-oral. • Trans-cervical +/- Mandibulotomy. • Trans-parotid. • Cervical-transpharyngeal “swing”. • Infratemporal fossa. • Transcervical-transmastoid.
  40. 40. Transoral • Has been used for small, benign tumors. • Very limited exposure and view. • Increased risk of tumor spillage. • Poor vascular control and risk of injury to neurovascular structures. • Not recommended.
  41. 41. Trans-cervical • With or without mandibulotomy • Transverse incision at level of hyoid, two fingers breadth below the mandible. • Submandibular gland displaced or removed. • Increase exposure by releasing digastric, stylohyoid, styloglossus from hyoid bone • Cut stylomandibular ligament +mandibulotomy
  42. 42. Transparotid • For deep lobe parotid tumors. • Superficial parotidectomy. • Facial nerve retracted. • Dissect around mandible. • May use mandibulotomy.
  43. 43. Cervical-parotid • Extend cervical incision up infront of ear. • Allows identification facial nerve. • Divide posterior belly digastric • Divide stylomandibular ligament, styloglossus, stylohyoid close to styloid process. • Can use mandibulotomy.
  44. 44. Cervical-transpharyngeal • “mandibular swing” • Large (greater than 8cm) • Highly vascular tumors. • Mandibulotomy anteriorly, incise along floor of mouth to anterior tonsillar pillar • Need a tracheostomy
  45. 45. Infratemporal fossa • Preauricular lateral infratemporal fossa approach. • Skull base +/- intra-cranial extension or infratemporal fossa involvement. • Can combine with frontotemporal craniotomy.
  46. 46. Transcervical-transmastoid • Cervical incision carried postauricularly • cortical mastoidectomy. • Remove mastoid tip exposing jugular fossa • Utilized to resect glomus vagale and jugulare tumors
  47. 47. Nonsurgical Management • Poor surgical canidates, failed balloon occlusion, elderly, unresectable lesions, would require sacrifice of multiple cranial nerves • Observation • Radiation
  48. 48. Observation • Paraganliomas grow 1.0-1.5 mm per year • Benign • Mortality less than 10% per year for untreated
  49. 49. Radiation • Not curable • Used for local control • Some shrink, mostly stops growth • Local control 90-100% reported
  50. 50. Key things to remember: • Prestyloid vs. retrostyloid • Pleomorphic most common prestyloid • Neurogenic tumors are retrostyloid • “Dumbbell” tumor • “salt and pepper” appearance • Most are benign • Surgery is mainstay of therapy
  51. 51. Thank you

×